Skip to main content
Download PDF

Prevalence and associated risk factors for sexual dysfunction among postmenopausal women: a study from Iran

Women's Midlife Health volume 7, Article number: 10 (2021) Cite this article

Abstract

Background

Female Sexual Dysfunction (FSD) is a distressing condition linked to menopause. This study aimed to determine the prevalence and contributing factors for FSD among postmenopausal women.

Methods

This was a cross-sectional study. A convenience sample of postmenopausal women attending a gynecology clinic in a teaching hospital affiliated with Tehran University of Medical Sciences was enrolled into the study. The Female Sexual Function Index (FSFI) was used to assess sexual function. In addition, demographic and psychosocial information were recorded. The association between sexual function and anxiety and depression were examined to explore the data.

Results

In all 162 postmenopausal women were studied. We performed general linear regression analysis to assess the relationship between sexual function and anxiety while including demographic variables in the model. The results showed that the model could explain about 46% of the variance observed in sexual function (adjusted R2 = 0.467). The analysis indicated that among independent variables, age (p <  0.001), sexual frequency (p <  0.001), and anxiety (p = 0.003) were significant contributing factors associated with sexual function. A similar analysis evaluating the relationship between sexual function and depression in menopausal women found that age (p <  0.001), sexual frequency (p <  0.001), and depression (p = 0.003), were significant contributing factors associated with sexual function; explaining about 46% of the variance observed (adjusted R2 = 0.466).

Conclusion

The findings showed that nearly half of menopausal women had sexual dysfunction in this convenience sample of women seeking gynecologic care. Women reporting sexual dysfunction also reported a higher prevalence of anxiety and depression. Indeed, recognition of such factors requires a holistic therapeutic approach to sexual dysfunction among postmenopausal women.

Background

Female Sexual Dysfunction (FSD) is one of the distressing conditions that affect many women worldwide [1]. Sexual dysfunction is not a single entity but a group of various adverse conditions including low sexual interest, arousal, orgasm, and satisfaction, and pain that leads to sexual dysfunction among women [2]. However, the transition from reproductive age to menopausal status might worsen this condition further, although controversy exists regarding the direct role of menopause on sexual dysfunction [3, 4]. Some investigators showed that sexual dysfunction could affect up to 60% of postmenopausal women [5, 6] most of whom would suffer from decreased sexual desire [7]. It is argued that the change in circulating sex hormones in postmenopausal women may influence emotional and cognitive aspects of sexuality, and thus sexual dysfunction in these women may occur more often [8].

Evidence suggests several factors affect sexual functioning in postmenopausal women. The most relevant variables are age, education, body image, general and mental health, achievement of reproductive goals, self-esteem, norms and experiences while, general and sexual health of the partner, and duration and quality of partnership are important also [9]. It is well documented that emotional distress and depression are independent risk factors for low sexual function in women [10].

Although prevalence and concerns about sexual dysfunction among Iranian women is well reported [11,12,13], information on sexual functioning among postmenopausal women is scarce. This study aimed to determine the prevalence and risk factors for sexual dysfunction among postmenopausal women. It was hoped that the findings from this study could contribute to the existing literature and help in designing appropriate interventions for this population.

Methods

Design and procedure

This was a cross-sectional study to assess sexual dysfunction among a sample of postmenopausal women in Tehran, Iran in 2018. Women who agreed to participate in the study were asked to respond to a questionnaire while they were waiting to visit a gynecologist.

Participants

The convenience sampling method was applied to recruit a sample of postmenopausal women attending a gynecology clinic in a teaching hospital affiliated with Tehran University of Medical Sciences during one calendar year. All women were attending the clinic either for routine care or other disease conditions. Information on menopausal status was recorded by a gynecologist. It was defined as no menstruation 12 months after the last normal menstrual period (LNMP). All women willing to participate were considered eligible except women using medications that affect sexual function; women who were sexually inactive; and women having a partner diagnosed with sexual dysfunction. The required sample size was estimated using Cochran’s formula (n = Z2 × pq/d2) considering the following parameters: Z = 1.96, p = 0.5, q = 0.5, d = 8%. As such we estimated that a study with a sample of 150 menopausal women would have 80% power at 5% significance level to detect sexual dysfunction. However, considering a 10% refusal, we aimed to recruit 165 menopausal women.

Independent variables

To describe the sample age, age at menopause, body mass index (BMI), sexual frequency, history of non-hormonal medication and gynecological surgery, and family size were recorded. In addition, the Hospital Anxiety and Depression Scale (HADS) was used to assess if women suffered from anxiety or depression or both [14]. The questionnaire contains 14 items where 7 items measure anxiety and 7 items measure depression. The score for each subscale ranges from 0 to 21. Scores of 11 or more on either subscale are considered to be a significant ‘case’ of psychological morbidity, while scores of 8–10 represent ‘borderline case’ and 0–7 are considered ‘normal’ [14]. We used the Iranian version of HADS that has proved to be a valid and reliable measure of anxiety and depression [15].

Dependent variables

The Female Sexual Function Index (FSFI) was used to measure sexual functioning. It is a 19-item questionnaire, which evaluates six domains of female sexual functioning during the past 4 weeks: desire, arousal, lubrication, orgasm, satisfaction, and pain during sexual intercourse [16]. Each item is scored from 0 to 5. The summed scores of each domain is multiplied by a certain coefficient (desire by 0.6, arousal and lubrication by 0.3, orgasm, satisfaction, and pain by 0.4) for a total score domain. The total FSFI score is the sum of these domain scores, with a minimum of 2 and a maximum of 36. The highest score shows the best sexual function and less pain [14]. The psychometric properties of the Iranian version of the FSFI are well documented [17].

Statistical analysis

Descriptive statistics including frequencies, means and standard deviations were used to explore the data. We used general linear regression analysis to evaluate the relationship between sexual function and independent variables including age, BMI, sexual frequency, anxiety, and depression. The selection of independent variables was based on findings from previous investigations. It has been shown that age, BMI, sexual frequency, anxiety, and depression could have a significant effect on the sexual function of postmenopausal women [18,19,20,21]. Of these, although the inclusion of sexual frequency in the model seems somewhat teleological (e.g. reduced arousal/desire so reduced frequency), evidence suggests that the frequency of sexual intercourse independently might play an important role in improved or decreased sexual function in postmenopausal women [22, 23]. However, due to the small sample size, we used a parsimonious mode. P-values less than 0.05 were considered statistically significant.

Results

In all, 165 menopausal women were approached and 162 women agreed to participate in the study. Three women refused to take part in the study due to dislike. The mean age (SD) of participant was 55.5 (6.16) ranging from 40 to 76 years. Thirty-five women (21.6%) received gynecological surgery. Many participants reported severe anxiety (59.9%) and depression (44.4%). Women’s characteristics including age, body mass index, frequency of sexual activity, history of surgery, medication, anxiety, and depression status are presented in Table 1.

Table 1 Clinical and demographic characteristics of 162 menopausal women seeking gynecological care: Tehran, Iran, 2018
Full size table

The mean sexual function score was 14.1 (SD = 8.13) out of 36.0. The results for sexual function and its sub-scales are shown in Table 2. The highest score was observed for the ‘pain’ sub-scale indicating less pain (mean = 3.04, SD = 2.18), and the lowest score was reported for ‘arousal’ indicating lower arousal in this sample (mean = 1.90, SD = 1.32).

Table 2 Mean and standard deviation (SD) on the female sexual function indexa among 162 menopausal women seeking gynecological care: Tehran, Iran, 2018
Full size table

We performed a general linear regression analysis to assess the relationship between sexual function and anxiety including the demographic variables in the model (Table 3). The results showed that the model could explain about 46% of the variance observed in sexual function (adjusted R2 = 0.467). The analysis indicated that among independent variables, age (p < 0.001), sexual frequency (p = < 0.001), and anxiety (p = 0.003) were significant contributing factors associated with sexual function. The findings indicated that older age, decreased sexual frequency and increased anxiety significantly contributed to decreased sexual function.

Table 3 General linear regression model for the association between anxiety and female sexual function index scores (n = 162): Tehran, Iran, 2018
Full size table

Similarly, when performing the analysis evaluating the relationship between sexual function and depression in postmenopausal women we found that age (p < 0.001), sexual frequency (p < 0.001), and depression (p = 0.003) were significant contributing factors associated with sexual function; explaining about 46% of the variance observed (adjusted R2 = 0.466) (Table 4). Again, the findings indicated that older age, decreased sexual frequency and increased depression significantly contributed to decreased sexual function.

Table 4 General linear regression model for the association between depression and female sexual function index scores (n = 162): Tehran, Iran, 2018
Full size table

Discussion

The findings from the current study showed that sexual dysfunction among postmenopausal women was associated with age, anxiety and depression. This observation could perhaps be explained in part by the fact that almost all women at this stage of life are experiencing changes in hormonal and physiological attributes that affect their sexual function and sexuality [24]. Additionally, other contributing factors might influence sexual dysfunction in this population.

The current study showed that anxiety and depression significantly were associated with sexual dysfunction. The association between psychological factors and sexual dysfunction are complicated and might be explained by the fact that postmenopausal women experience lower self-esteem, and weaker body image where both factors lead to reduced sexual desire. In fact, self-esteem and body image contribute to anxiety and depression and these in turn lead to less sexual function [9]. On the other hand, one might argue that less sexual functioning in postmenopausal women by itself might cause anxiety and depression and thus there is a circular pathway between psychological factors and sexual dysfunction in women who experience menopause. Furthermore, some women feel less sexually attractive since they tend to gain weight as their metabolism slows down. For some women, this weight gain harms body image and self-esteem and may lead to mild to moderate depression [25].

The findings showed that problems in arousal was the most common sexual dysfunction reported in these postmenopausal women while other studies found that desire [26], lubrication, dyspareunia, and arousal [27, 28] were the most common sexual problems among postmenopausal women. Perhaps the differences observed between the affected domains of sexual dysfunction in various studies might be due to variations in life style and level of physical activity and other cultural and socioeconomic factors [29,30,31].

We found that sexual frequency, anxiety, and depression independently associated with sexual function. These findings are in line with other studies on the topic [4, 32]. The relationship between mental health and sexual dysfunction is well documented [33]. Previous research on the predictive role of demographic factors in sexual problems has shown a negative association between age and sexual function. Some studies have even found that a spouse’s age is a very influential factor in women’s sexual function [34, 35]. However, the differences in sexual dysfunction in older women might be due to the different research methods, the measures used in various studies, different cut-off points selected in the studies, different living condition, racial, religious, and cultural and attitudinal factors [36,37,38,39].

The relationship between moderate/severe sexual dysfunction with non-regular weekly intercourse has been previously documented in women of all ages [4]. It warrants further interventional research inquiring into whether encouraging more intercourses can improve the sexual function of postmenopausal women. It seems quite reasonable to consider that non-regular and unsatisfactory sexual intercourses act as a vicious cycle since the less frequently postmenopausal woman has intercourses, the more likely she will suffer sexual dysfunction. One might argue that a majority of these women avoid more sexual intercourse due to pain, feeling unwanted, being anxious, and being uneducated about lubrication and how to have better intercourse, although the current study did not describe such observation. Altogether, we know that FSD is a well-known problem in postmenopausal women due to its multi-facet psycho-socio-biological nature, which necessitates a holistic approach [7, 32, 40, 41].

Sexual function components may be affected by menopause due to changes in sensory perception, central and peripheral nerves, peripheral blood flow, and the capacity to create muscle tension in response to estrogen deficiency. These changes may lead to lower self-esteem, weaker body image, and reduced sexual desire. Some women feel less sexually attractive or less satisfied with their bodies. In fact, their self-image can change because they tend to gain weight as they age and their metabolism slows down. Thus, depression and emotional distress, in turn, can be a risk factor for sexual dysfunction [22, 42], and it can be imagined a mutual relationship between emotional state and sexual function.

The present study had some limitations. This was a cross-sectional study and thus the findings should be interpreted with caution. Secondly, we could not measure the hormonal status of the participants and therefore the clinical application of the study is limited. We suggest conducting interventional studies for changing those modifiable risk factors associated with FSD in postmenopausal women.

Conclusion

The findings showed that nearly half of menopausal women had sexual dysfunction in this convenience sample of women seeking gynecologic care. Those who were noted to have sexual dysfunction also reported a higher prevalence of anxiety and depression. Indeed, recognition of such factors requires a holistic therapeutic approach to sexual dysfunction among postmenopausal women.

Availability of data and materials

The data used and analyzed for writing this manuscript are available on request from the corresponding authors.

Abbreviations

BMI:

Body mass index

FSD:

Female Sexual Dysfunction

FSFI:

Female Sexual Function Index

HADS:

Hospital Anxiety and Depression Scale

References

  1. McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Res. 2016;13(2):135–43.

    Google Scholar 

  2. Binik YM, Brotto LA, Graham CA, Segraves RT. Response of the DSM-V sexual dysfunctions subworkgroup to commentaries published in JSM. J Sex Res. 2010;7(7):2382–7.

    Google Scholar 

  3. Bachmann GA. Influence of menopause on sexuality. Int J Fertil Menopausal Stud. 1995;40:16–22.

    PubMed  Google Scholar 

  4. Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res. 2006;18(4):382–95.

    Article  PubMed  CAS  Google Scholar 

  5. Graziottin A, Koochaki PE, Rodenberg CA, Dennerstein L. The prevalence of hypoactive sexual desire disorder in surgically menopausal women: an epidemiological study of women in four European countries. J Sex Res. 2009;6(8):2143–53.

    Google Scholar 

  6. West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med. 2008;168(13):1441–9.

    Article  PubMed  Google Scholar 

  7. Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Arch Sex Behav. 2010;39(2):221–39.

    Article  PubMed  Google Scholar 

  8. Nappi RE, Cucinella L, Martella S, Rossi M, Tiranini L, Martini E. Female sexual dysfunction (FSD): prevalence and impact on quality of life (QoL). Maturitas. 2016;94:87–91.

    Article  PubMed  Google Scholar 

  9. McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R, Fisher AD, et al. Risk factors for sexual dysfunction among women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med. 2016;13(2):153 167.

    Article  PubMed  Google Scholar 

  10. Lianjun P, Aixia Z, Zhong W, Feng P, Li B, Xiaona Y. Risk factors for low sexual function among urban Chinese women: a hospital-based investigation. J Sex Med. 2011;8(8):2299–304.

    Article  PubMed  Google Scholar 

  11. Merghati-Khoei E, Sheikhan F, Shamsalizadeh N, Haghani H, Yousofnia Pasha YR, Killeen T. Menopause negatively impacts sexual lives of middle-aged Iranian women: a cross-sectional study. J Sex Marital Ther. 2014;40(6):552–60.

    Article  PubMed  Google Scholar 

  12. Hashemi S, Tehrani FR, Simbar M, Abedini M, Bahreinian H, Gholami R. Evaluation of sexual attitude and sexual function in menopausal age; a population based cross-sectional study. Iran J Reprod Med. 2013;11(8):631–6.

    PubMed  PubMed Central  Google Scholar 

  13. Masoumi M, Azizi M, Atarod Z, Gartoulla P, Abdollahi F, Fooladi E. A systematic review of prevalence of vasomotor and sexual symptoms among Iranian middle-aged women. Iran Red Crescent Med J. 2017;19(4):e43952.

    Article  Google Scholar 

  14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    Article  PubMed  CAS  Google Scholar 

  15. Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The hospital anxiety and depression scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2013;1:14.

    Article  Google Scholar 

  16. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.

    Article  PubMed  CAS  Google Scholar 

  17. Mohammadi kh, Heydari M, Faghihzadeh S. The female sexual function index (FSFI): validation of the Iranian version. Payesh. 2008;7:269–78.

    Google Scholar 

  18. Faubion SS, Fairbanks F, Kuhle CL, Sood R, Kling JM, Vencill JA, et al. Association between body mass index and female sexual dysfunction: a cross-sectional study from the data registry on experiences of aging, menopause, and sexuality. J Sex Med. 2020;17(10):1971–80.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Reid R, Abramson BL, Blake J, Desindes S, Dodin S, Johnston S, et al. Sexuality and menopause. J Obstet Gynaecol Can. 2014;36(9):S59–73.

    Google Scholar 

  20. Schnatz PF, Whitehurst SK, O'Sullivan DM. Sexual dysfunction, depression, and anxiety among patients of an inner-city menopause clinic. J Women's Health (Larchmt). 2010;19(10):1843–9.

    Article  Google Scholar 

  21. Yangin HB, Sözer GA, Sengün N, Kukulu K. The relationship between depression and sexual function in menopause period. Maturitas. 2008;61(3):233–7.

    Article  PubMed  Google Scholar 

  22. Thornton K, Chervenak J, Neal-Perry G. Menopause and sexuality. Endocrinol Metab Clin N Am. 2015;44(3):649–61.

    Article  Google Scholar 

  23. Harder H, Starkings RML, Fallowfield LJ, Menon U, Jacobs IJ, Jenkins VA, et al. Sexual functioning in 4,418 postmenopausal women participating in UKCTOCS: a qualitative free-text analysis. Menopause. 2019;26(10):1100–009.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ornat L, Martínez-Dearth R, Muñoz A, Franco P, Alonso B, Tajada M, et al. Sexual function, satisfaction with life and menopausal symptoms in middle-aged women. Maturitas. 2013;75:261–9.

    Article  PubMed  Google Scholar 

  25. Mezones-Holguin E, Córdova-Marcelo W, Lau-Chu-Fon F, Aguilar-Silva C, Morales-Cabrera J, Bolaños-Díaz R, et al. Association between sexual function and depression in sexually active, mid-aged, Peruvian women. Climacteric. 2011;14:654–60.

    Article  PubMed  CAS  Google Scholar 

  26. Dąbrowska-Galas M, Dąbrowska J, Michalski B. Sexual dysfunction in menopausal women. J Sex Med. 2019;7(4):472–9.

    Article  Google Scholar 

  27. Ghazanfarpour M, Khadivzadeh T, Latifnejad Roudsari R, Mehdi Hazavehei SM. Obstacles to the discussion of sexual problems in menopausal women: a qualitative study of healthcare providers. J Obstet Gynaecol. 2017;37(5):660–6.

    Article  PubMed  Google Scholar 

  28. Castelo-Branco C, Cancelo MJ, Chedraui P. Female sexual dysfunction in postmenopausal women. Expert Opin Ther Pat. 2007;17(6):639–47.

    Article  CAS  Google Scholar 

  29. Dąbrowska J, Dąbrowska-Galas M, Naworska B, Wodarska M, Plinta R. The role of physical activity in preventing obesity in midlife women. Menopause Rev. 2015;14(1):13–9.

    Article  Google Scholar 

  30. Grindler NM, Allsworth JE, Macones GA, Kannan K, Roehl KA, Cooper AR. Persistent organic pollutants and early menopause in US women. PLoS One. 2015;10(1):e0116057.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynaecol. 2000;96(3):351–8.

    CAS  Google Scholar 

  32. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS). Menopause. 2006;13(1):46–56.

    Article  PubMed  Google Scholar 

  33. McCool-Myers M, Theurich M, Zuelke A, et al. Predictors of female sexual dysfunction: a systematic review and qualitative analysis through gender inequality paradigms. BMC Womens Health. 2018;18:108.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Chedraui P, Pérez-López FR, Sánchez H, Aguirre W, Martínez N, Miranda O, et al. Assessment of sexual function of mid-aged Ecuadorian women with the 6-item female sexual function index. Maturitas. 2012;71(4):407–12.

    Article  PubMed  Google Scholar 

  35. Chedraui P, Pérez-López FR, Mezones-Holguin E, San Miguel G, Avila C, Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Assessing predictors of sexual function in mid-aged sexually active women. Maturitas. 2011;68(4):387–90.

    Article  PubMed  Google Scholar 

  36. Jamali S, Javadpour S, Mosalanejad L, Parnian R. Attitudes about sexual activity among postmenopausal women in different ethnic groups: a cross-sectional study in Jahrom, Iran. J Reprod Infertil. 2016;17(1):47–55.

    PubMed  PubMed Central  Google Scholar 

  37. Jamali S, Rahmanian A, Javadpour S. Examining the sexual function and related attitudes among aged women: a cross-sectional study. Inter J R Biomed. 2016;14(1):29–38.

    Google Scholar 

  38. Charandabi SM, Rezaei N, Hakimi S, Montazeri A, Taheri S, Taghinejad H, et al. Quality of life of postmenopausal women and their spouses: a community-based study. Iran Red Crescent Med J. 2015;17(3):e21599.

    Google Scholar 

  39. Nazarpour S, Simbar M, Tehrani FR, Majd HA. Sexual function and exercise in postmenopausal women residing in Chalous and Nowshahr, northern Iran. Iran Red Crescent Med J. 2016;18(5):e30120.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes. 2005;3(1):47.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Prairie BA, Wisniewski SR, Luther J, Hess R, Thurston RC, Wisner KL, et al. Symptoms of depressed mood, disturbed sleep, and sexual problems in midlife women: cross-sectional data from the Study of Women’s Health across the Nation. J Women's Health (Larchmt). 2015;24(2):119–26.

    Article  Google Scholar 

  42. Scott VC. The impact of depression and health on sexual satisfaction for older couples. Provo: Brigham Young University; 2011. [Thesis] https://scholarsarchive.byu.edu/etd/2755/.

    Google Scholar 

Download references

Acknowledgments

The authors are grateful to all participants who made this study possible.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Psychology, Faculty of Education and Psychology, Alzahra University, Tehran, Iran

    Azadeh Tavoli

  2. Department of Obstetrics and Gynecology, School of Medicine, Tehran University of Medical Science, Tehran, Iran

    Zahra Tavoli

  3. Department of Psychiatry, School of Medicine, Tehran University of Medical Science, Tehran, Iran

    Mohammad Effatpanah

  4. Population Health Research Group, Health Metrics Research Centre, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran

    Ali Montazeri

  5. Faculty of Humanity Sciences, University of Science and Culture, Tehran, Iran

    Ali Montazeri

Authors
  1. Azadeh Tavoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zahra Tavoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Effatpanah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ali Montazeri
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AT contributed to design, data collection and writing process. ZT contributed to design, analysis and wrote the first draft. ME contributed to project management, data collection and writing. AM did analyses, contributed to interpretation of findings, and provided the final draft and responded to reviewers’ comments. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Zahra Tavoli or Ali Montazeri.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Tehran University of Medical Science. The written informed consent was obtained from all participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tavoli, A., Tavoli, Z., Effatpanah, M. et al. Prevalence and associated risk factors for sexual dysfunction among postmenopausal women: a study from Iran. womens midlife health 7, 10 (2021). https://doi.org/10.1186/s40695-021-00069-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40695-021-00069-0

Keywords

Women's Midlife Health

ISSN: 2054-2690

Contact us